The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
953
July 21, 1995
View Complete Issue         Table of Contents 2019 
Naltrexone For Alcohol Dependence
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Naltrexone For Alcohol Dependence
July 21, 1995 (Issue: 953)
Naltrexone (ReVia -DuPont Pharma), a long-acting oral opioid antagonist previously marketed for treatment of opioid dependence under the trade name Trexan, was recently approved by the US Food and Drug Administration (FDA) for treatment of alcohol ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Naltrexone For Alcohol Dependence
Article code: 953b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.